ELOVL2: a novel tumor suppressor attenuating tamoxifen resistance in breast cancer.
Jeong D, Ham J, Kim HW, Kim H, Ji HW, Yun SH, Park JE, Lee KS, Jo H, Han JH, Jung SY, Lee S, Lee ES, Kang HS, Kim SJ.
Jeong D, et al. Among authors: jung sy.
Am J Cancer Res. 2021 Jun 15;11(6):2568-2589. eCollection 2021.
Am J Cancer Res. 2021.
PMID: 34249416
Free PMC article.